It was found that SREBF2 is one of the mediators of the tumor suppressor activity of miR-28-5p in prostatic carcinoma cells, and the inhibition of SREBF2 expression can significantly affect the progression of prostate tumors [5]. Here, SREBF2 is linked to neoplasm.